about
3.0 T proton magnetic resonance spectroscopy of the liver: quantification of cholineMolecular preservation by extraction and fixation, mPREF: a method for small molecule biomarker analysis and histology on exactly the same tissue.Imaging and 'omic' methods for the molecular diagnosis of cancer.A phase and frequency alignment protocol for 1H MRSI data of the prostate.Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopyQuantitative proton MR spectroscopy as a biomarker of tumor necrosis in the rabbit VX2 liver tumor.Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.Reliable non-invasive measurement of human neurochemistry using proton spectroscopy with an anatomically defined amygdala-specific voxelNew agents and techniques for imaging prostate cancer.PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.Molecular imaging as a tool for translating breast cancer scienceTranslational Molecular Imaging of Prostate Cancer.Biomarkers and imaging: physics and chemistry for noninvasive analyses.Metabolomics in urogenital cancer.High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.Molecular origin of plasma membrane citrate transporter in human prostate epithelial cells.Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r.Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens.Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.Application of compressed sensing to multidimensional spectroscopic imaging in human prostate.Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia.
P2860
Q30608766-2E4D29C1-8A75-40E6-8FDE-77148FFAECC2Q31043717-0BFECEB4-DB92-4721-B208-2B79EEDB1DCEQ33577268-0D0DD243-F534-42DB-B0C7-892E0834A41AQ34033324-EFDF09BB-0238-415B-AAD6-E1633A3F3CF2Q35095985-022EF884-D4CC-4375-AEC1-6CAB24D3029DQ35101056-7252C6FC-356C-4737-8F9B-E73488E057B3Q35141481-A36437A5-4A17-443C-8F8B-5A7263ABB4AAQ35663598-507E167E-AE06-4B8D-9FD6-3C001917F636Q35911784-43302975-6FEF-491C-AA9A-CF55E0875A2AQ36357752-6BF2F7C2-A615-4020-B808-B4F57AB734BEQ36795496-E653B553-508A-4546-B495-9907AE0A63FCQ37019264-9E494395-EBFF-4898-921C-EA34E9EAEC7CQ37244969-93FAB5A9-4315-4AF3-99EB-3C63059CE5C5Q37810197-49B279AC-3E69-471F-AE1A-D1EE51EAD42CQ37867682-DE7917AC-9759-409F-9F47-EFD708603440Q38119455-AA64E26B-DB09-4431-912A-4C1023FF592CQ39706752-916935E6-8B1F-4541-A962-5FE0801F3A75Q39795389-E8CE0736-CA6D-46B3-AB05-82057A2C8618Q43095308-B3BAA8D6-8F78-44DB-B599-554EF0FFA7DFQ43193122-D7A2CB1E-5DA6-476B-BCE3-2CEF1949D551Q44179353-6197F76C-49DF-4405-AE99-71638DC00677Q55198006-1DDAF791-7629-4564-8017-6F5CD26A671D
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Proton MR spectroscopy of the prostate.
@en
type
label
Proton MR spectroscopy of the prostate.
@en
prefLabel
Proton MR spectroscopy of the prostate.
@en
P1476
Proton MR spectroscopy of the prostate.
@en
P2093
Michael K Scherr
Ullrich G Mueller-Lisse
P304
P356
10.1016/J.EJRAD.2007.06.024
P577
2007-08-20T00:00:00Z